Alternative splicing and cancer: a systematic review
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
The abnormal regulation of alternative splicing is usually accompanied by the occurrence and development of tumors, which would produce multiple different isoforms and diversify protein expression. The aim of the present study was to conduct a systematic review in order to describe the regulatory mechanisms of alternative splicing, as well as its functions in tumor cells, from proliferation and apoptosis to invasion and metastasis, and from angiogenesis to metabolism. The abnormal splicing events contributed to tumor progression as oncogenic drivers and/or bystander factors. The alterations in splicing factors detected in tumors and other mis-splicing events (i.e., long non-coding and circular RNAs) in tumorigenesis were also included. The findings of recent therapeutic approaches targeting splicing catalysis and splicing regulatory proteins to modulate pathogenically spliced events (including tumor-specific neo-antigens for cancer immunotherapy) were introduced. The emerging RNA-based strategies for the treatment of cancer with abnormally alternative splicing isoforms were also discussed. However, further studies are still required to address the association between alternative splicing and cancer in more detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–209 of 209
Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis
Wang, H., Zhang, N., Wu, X., Zheng, X. Y., Ling, Y., & Gong, Y. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03843-3 · Cited by 24
Characterization of cis-acting elements that control oscillating alternative splicing
Goldammer, G., Neumann, A., Strauch, M., Müller-McNicoll, M., Heyd, F., & Preußner, M. (2018) · RNA Biology · doi:10.1080/15476286.2018.1502587 · Cited by 23
Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma
Luzina, I. G., Lockatell, V., Lavania, S., Pickering, E. M., Kang, P. H., Bashkatova, Y. N., Михайлович, А. С., & Atamas, S. P. (2012) · Cytokine · doi:10.1016/j.cyto.2011.12.017 · Cited by 22
Vries, I. S. N., Sackmann, Y., Klein, F., Ostareck‐Lederer, A., Ostareck, D. H., Jost, E., Ehninger, G., Brümmendorf, T. H., Marx, G., Röllig, C., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.11.007 · Cited by 19
Allosteric regulation of U1 snRNP by splicing regulatory proteins controls spliceosomal assembly
Shenasa, H., Movassat, M., Forouzmand, E., & Hertel, K. J. (2020) · RNA · doi:10.1261/rna.075135.120 · Cited by 19
Role of heterogeneous nuclear ribonucleoprotein K in tumor development
Chen, Y., Zeng, Y., Xiao, Z. Y., Chen, S., Li, Y., Zou, J., & Zeng, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28867 · Cited by 16
Downregulation of HNRNPK in human cancer cells inhibits lung metastasis
Li, M., Zhang, W., Yang, X., Liu, H., Cao, L., Li, W., Wang, L., Zhang, G., & Gao, R. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12090 · Cited by 12
The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients
Morikawa, T., Manabe, T., Ito, Y., Yamada, S., Yoshimi, A., Nagai, T., Ozaki, N., & Mayeda, A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.011 · Cited by 11
Zhou, H., Liu, X., Yu, R., Long, T., Zhao, R., Liu, H., Xu, Y., Liang, J. G., & Liang, P. (2016) · Genes and Immunity · doi:10.1038/gene.2016.13 · Cited by 3
Cited by
Deep Visual Proteomics defines single-cell identity and heterogeneity
Mund, A., Coscia, F., Kriston, A., Hollandi, R., Kovács, F., Brunner, A.-D., Migh, E., Schweizer, L., Santos, A., Bzorek, M., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01302-5 · Cited by 562
Alternative splicing and related RNA binding proteins in human health and disease
Tao, Y., Zhang, Q., Wang, H., Yang, X., & Mu, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01734-2 · Cited by 320
Neoantigen: A New Breakthrough in Tumor Immunotherapy
Zhang, Z., Lu, M., Qin, Y., Gao, W., Tao, L., Su, W., & Zhong, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672356 · Cited by 284
Rammohan, M., Harris, E., Bhansali, R. S., Zhao, E., Li, L. S., & Crispino, J. D. (2022) · Oncogene · doi:10.1038/s41388-022-02245-6 · Cited by 68
Challenges in Therapeutically Targeting the RNA‐Recognition Motif
Schmeing, S., & Hart, P. '. (2024) · WIREs RNA · doi:10.1002/wrna.1877 · Cited by 11
Metadata
- Authors
- Zhang, Y., Qian, J., Gu, C., & Yang, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-02-24
- Volume
- 6
- Issue
- 1
- Pages
- 78-78
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W3132948359
- Cited by
- 497
- References
- 209
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.